Skip to content

The hair follicle implant system is used to study the safety and efficacy of hair follicle extraction and implantation in male androgenetic alopecia patients

The hair follicle implant system is used to study the safety and efficacy of hair follicle extraction and implantation in male androgenetic alopecia patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093712
Enrollment
Unknown
Registered
2024-12-10
Start date
2024-12-10
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male androgenic alopecia

Interventions

Control group:The same surgical team used the hair follicle implant system for hair follicle extraction and hair follicle implantation (same patient trial side)
Study group:FUE hair follicle extraction and artificial hair follicle implantation by the same surgical team (same patient control side)

Sponsors

Jing'an District Central Hospital Of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Male aged 18-60 years old; 2.Androgenic alopecia patients, with a baldness grade of Norwood Hamilton II-VI; 3.Stable for more than one year; 4.Agree to shave hair to 1-1.4mm and accept color markings; 5.Agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Individuals with serious internal or surgical illnesses, as well as active infectious diseases; 2.Individuals with severe mental and psychological disorders; 3.Patients with scar constitution; 4.Patients who have undergone hair transplant surgery in the past; 5.Individuals with autoimmune diseases and immunosuppression status; 6.There are other scalp diseases present; 7.Participants who have participated in other clinical trials simultaneously in the past six months; 8.Other patients who have been determined by researchers to not meet the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Success rate of immediate hair follicle implantation during surgery;

Secondary

MeasureTime frame
Hair follicle extraction cross-sectional rate;Hair follicle abandonment rate;Incidence of postoperative complications;Incidence of adverse events and serious adverse events related to medical devices;The incidence of other adverse (serious adverse) events during the study period;

Countries

China

Contacts

Public ContactWenyu Wu

Huashan Hospital, Fudan University

william88888@139.com+86 21 61578275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026